Prospective Evaluation of Two Dosing Equations for Theophylline in Premature Infants
dc.contributor.author | Bhatt‐mehta, Varsha | en_US |
dc.contributor.author | Donn, Steven M. | en_US |
dc.contributor.author | Schork, M. Anthony | en_US |
dc.contributor.author | Reed, Susan | en_US |
dc.contributor.author | Johnson, Cary E. | en_US |
dc.date.accessioned | 2012-03-16T15:55:19Z | |
dc.date.available | 2012-03-16T15:55:19Z | |
dc.date.issued | 1996-09-10 | en_US |
dc.identifier.citation | Bhatt‐mehta, Varsha ; Donn, Steven M.; Schork, M. Anthony; Reed, Susan; Johnson, Cary E. (1996). "Prospective Evaluation of Two Dosing Equations for Theophylline in Premature Infants." Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 16(5). <http://hdl.handle.net/2027.42/90141> | en_US |
dc.identifier.issn | 0277-0008 | en_US |
dc.identifier.issn | 1875-9114 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/90141 | |
dc.publisher | Wiley Periodicals, Inc. | en_US |
dc.publisher | Blackwell Publishing Ltd | en_US |
dc.title | Prospective Evaluation of Two Dosing Equations for Theophylline in Premature Infants | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Pharmacy and Pharmacology | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Biostatistics, University of Michigan, Ann Arbor, Michigan. | en_US |
dc.contributor.affiliationum | Pediatrics and Communicable Diseases, Section of Neonatal‐Perinatal Medicine, University of Michigan, Ann Arbor, Michigan | en_US |
dc.contributor.affiliationum | College of Pharmacy and the Departments of Pharmacy, University of Michigan, Ann Arbor, Michigan | en_US |
dc.identifier.pmid | 8888073 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/90141/1/j.1875-9114.1996.tb02995.x.pdf | |
dc.identifier.doi | 10.1002/j.1875-9114.1996.tb02995.x | en_US |
dc.identifier.source | Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy | en_US |
dc.identifier.citedreference | Gilman JT, Gal P, Levine RS, Hersh CB, Erkan NV. Factors influencing theophylline disposition in 179 newborn infants. Ther Drug Monit 1986; 8: 4 – 10. | en_US |
dc.identifier.citedreference | Moore ES, Faix RG, Banagale RC et al. The population pharmacokinetics of theophylline in neonates and young infants. J Pharmacokinet Biopharm 1989; 17: 47 – 66. | en_US |
dc.identifier.citedreference | Jones RAK, Baillie E. Dosage schedule for iv aminophylline in apnoea of prematurity, based on pharmacokinetic studies. Arch Dis Child 1979; 54: 190 – 3. | en_US |
dc.identifier.citedreference | Bhatt‐Mehta V, Johnson CE, Donn SM, Theisen V. Accuracy and reliability of dosing equations to individualize theophylline treatment in apnea of prematurity. Pharmacotherapy 1995; 15: 246 – 50. | en_US |
dc.identifier.citedreference | Nassif EG, Weinberger MN, Shannon D et al. Theophylline disposition in infancy. J Pediatr 1981; 98: 158 – 60. | en_US |
dc.identifier.citedreference | Anonymous. Theophylline. In: Rowe PC ed.. Johns Hopkins, the Harriet Lane handbook, 12th ed. Chicago: Year Book, 1991: 237. | en_US |
dc.identifier.citedreference | Viscardi RM, Faix RG, Nicks JJ, Grasela TH. Efficacy of theophylline for prevention of post‐extubation respiratory failure in very low birth weight infants. J Pediatr 1985; 107: 469 – 72. | en_US |
dc.identifier.citedreference | Hendeles L, Weinberger M, Johnson G. Theophylline. In: Evans WE, Schentag JJ, Jusko WJ eds.. Applied pharmacokinetics. San Francisco: Applied Therapeutics, 1980: 95 – 138. | en_US |
dc.identifier.citedreference | Donn SM, Roloff DW, Goldstein GW. Prevention of intraventricular hemorrhage in preterm infants by phenobarbitone. Lancet 1981; 2: 215 – 17. | en_US |
dc.identifier.citedreference | Anonymous. Use of theophylline in infants. FDA Drug Bull 1985; 15: 16 – 17. | en_US |
dc.identifier.citedreference | Lonnerholm G, Lindstrom B, Paalow L, Sedin G. Serum theophylline and caffeine clearance during first year of life. Eur J Clin Pharmacol 1983; 24: 371 – 80. | en_US |
dc.identifier.citedreference | Bada HS, Khanna NN, Somani SM, Tin TT. Interconversion of theophylline and caffeine in newborn infants. J Pediatr 1979; 94: 993 – 5. | en_US |
dc.identifier.citedreference | Gilman JT, Gal P. Inadequacy of FDA guidelines for theophylline use in neonates. Drug Intell Clin Pharm 1986; 20: 481 – 4. | en_US |
dc.identifier.citedreference | Murphy JE, Erkan NV, Fakhreddine F. New FDA guidelines for theophylline dosing in infants [letter]. Clin Pharm 1986; 5: 16. | en_US |
dc.identifier.citedreference | Hogue SL, Phelps SJ. Evaluation of three dosing equations in infants less than or equal to one year of age. Clin Res 1990; 38: 982A. | en_US |
dc.identifier.citedreference | Landay RA, Gonzalez MA, Taylor JC. Effect of phenobarbital on theophylline disposition. J Allergy Clin Immunol 1978; 62: 27 – 9. | en_US |
dc.identifier.citedreference | Yeung CY, Tam LS, Chan A, Lee KH. Phenobarbitone prophylaxis for neonatal hyperbilirubinemia. Pediatrics 1971; 48: 372 – 6. | en_US |
dc.identifier.citedreference | Valdes OS, Maurer HM, Shumway CN, Draper DA, Hossaini AA. Controlled clinical trial of phenobarbital and/or light in reducing neonatal hyperbilirubinemia in a predominantly negro population. J Pediatr 1971; 79: 1015 – 17. | en_US |
dc.identifier.citedreference | Aranda JV, Grondin D, Sasynick BI. Pharmacologic considerations in the therapy of neonatal apnea. Pediatr Clin North Am 1981; 28: 113 – 33. | en_US |
dc.identifier.citedreference | Grasela TH, Donn SM. Neonatal population pharmacokinetics of phenobarbital derived from routine clinical data. Dev Pharmacol Ther 1985; 8: 374 – 83. | en_US |
dc.identifier.citedreference | Tserg K, Takieddine FN, King KC. Developmental aspects of theophylline metabolism in premature infants. Clin Pharmacol Ther 1983; 33: 522 – 8. | en_US |
dc.identifier.citedreference | Shannon DC, Gotay F, Stein IM, Rogers MC, Todres ID, Moylan FMB. Prevention of apnea and bradycardia in low birth weight infants. Pediatrics 1975: 55: 589 – 94. | en_US |
dc.identifier.citedreference | Alden ER, Mandelkorn T, Woodrum DE, Wennberg RP, Parks CR, Hodson WA. Morbidity and mortality of infants weighing less than 1000 grams in an intensive care nursery. Pediatrics 1972; 50: 40 – 9. | en_US |
dc.identifier.citedreference | Daily WJR, Klaus M. Apnea in premature infants: monitoring, incidence, heart rate changes, and effect of environmental temperature. Pediatrics 1969; 43: 510 – 18. | en_US |
dc.identifier.citedreference | Henderson‐Smart DJ, Pettigrew AG, Campbell DJ. Clinical apnea and brainstem neural function in preterm infants. N Engl J Med 1983; 308: 353 – 7. | en_US |
dc.identifier.citedreference | Martin RJ, Miller MJ, Carlo WA. Pathogenesis of apnea in preterm infants. J Pediatr 1986; 109: 733 – 41. | en_US |
dc.identifier.citedreference | Gerhardt T, McCarthy J, Bancalari E. Effect of aminophylline on respiratory center and reflex activity in premature infants with apnea. Pediatr Res 1983; 17: 199 – 201. | en_US |
dc.identifier.citedreference | Uauy R, Shapiro DL, Smith B, Warshaw JB. Treatment of severe apnea in prematures with orally administered theophylline. Pediatrics 1975; 55: 595 – 8. | en_US |
dc.identifier.citedreference | Davi MJ, Sankaran K, Simons KJ et al. Physiologic changes induced by theophylline in the treatment of apnea in preterm infants. J Pediatr 1978; 92: 91 – 5. | en_US |
dc.identifier.citedreference | Peabody J, Neese AL, Lucey JF et al. Decreased hypoxic, hyperoxic and bradycardic episodes as responses of neonates to theophylline. Pediatr Res 1977; 11: 419. | en_US |
dc.identifier.citedreference | Aranda JV, Sitar DS, Parsons WD et al. Pharmacokinetic aspects of theophylline in premature newborns. N Engl J Med 1976; 295: 413 – 16. | en_US |
dc.identifier.citedreference | Giacoia G, Jusko WJ, Menke J et al. Theophylline pharmacokinetics in premature infants with apnea. J Pediatr 1976; 89: 829 – 32. | en_US |
dc.identifier.citedreference | Cummiskey JM, Popa V. State‐of‐the‐art: pharmacologic‐therapeutic update, theophyllines: a review. J Asthma 1984; 21: 243 – 57. | en_US |
dc.identifier.citedreference | Stile IL, Zolfaghari S, Hiatt IM et al. Pharmacokinetics of theophylline in premature infants on the first day of life. Clin Ther 1986; 8: 336 – 41. | en_US |
dc.identifier.citedreference | Takieddine FN, Tserng K, King KC et al. Postnatal development of theophylline metabolism in preterm infants. Semin Perinatol 1981; 5: 351 – 8. | en_US |
dc.identifier.citedreference | Estelle F, Simons R, Rigatto H et al. Pharmacokinetics of theophylline in neonates. Semin Perinatol 1981; 5: 337 – 45. | en_US |
dc.identifier.citedreference | Kraus DM, Fischer JH, Reitz SJ et al. Alterations in theophylline metabolism during the first year of life. Clin Pharmacol Ther 1993; 54: 351 – 9. | en_US |
dc.identifier.citedreference | Gal P, Boer H, Toback J et al. Effect of asphyxia on theophylline clearance in newborns. South Med J 1982; 75: 836 – 8. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.